Imohgen Alo rang the bell at John Hunter Children's Hospital on Friday to mark the end of her cancer treatment. The NSW Lake Macquarie region resident was diagnosed with T-cell lymphoma, a blood ...
Detailed price information for Citius Pharmaceuticals Inc (CTXR-Q) from The Globe and Mail including charting and trades.
Fitgurú on MSN
From pilates studio to oncology ward: The "flu" that was actually aggressive brain cancer
When a high-performance fitness instructor’s "exhaustion" turned out to be a deadly lymphoma, a cutting-edge "Pac-Man" ...
She thought it was a case of the flu. As the weeks passed, the Pilates instructor's symptoms worsened. Weiss could no longer ...
3d
Lyell Immunopharma, Inc. (LYEL) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Lyell Immunopharma, Inc. ( LYEL) TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM EST ...
CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone ...
The pleural effusion that was initially drained recurred after two weeks but subsequently resolved on follow‑up imaging as part of the patient’s response to chemotherapy. Repeat LDH measurement was ...
After a median follow-up of 13.3 months (95% CI, 9.04-18.69), the median duration of response was 18.1 months, progression ...
9d
A college student thought she had a UTI. Then came fevers, fatigue and pain: "Something's not right"
Emma Operacz was diagnosed with a rare cancer at 21. An unusual treatment and bone marrow donation from her sister saved her ...
NICE recommends epcoritamab for relapsed follicular lymphoma, offering a new option after multiple lines of therapy.
Abstract: Esophageal squamous cell carcinoma (ESCC) is a highly aggressive cancer with poor prognosis. Accurate prognostic models are essential for guiding personalized treatment strategies. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results